A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

Clinical trial NCT02038699 · WITHDRAWN

Trial details

NCT number: NCT02038699
Sponsor: Jazz Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Glioblastoma Advanced Colorectal Cancer Advanced Triple-negative Breast Cancer Advanced Non-small Cell Lung Cancer

Start date: 2014-01-01
Primary completion: 2015-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.